Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Zinc finger protein 738 pseudogene (ENSG00000269839) is a genomic sequence with high similarity to the ZNF738 protein-coding gene but contains mutations or deletions that prevent the production of a functional zinc finger protein[11][5]. While the parental gene, ZNF738, is predicted to have DNA-binding ability and ubiquitin-protein transferase activity, and may play roles in transcriptional regulation[1][9], its pseudogene is considered non-functional, with no known biological activity, no established role in disease, and no relevance as a drug target. Pseudogenes sometimes produce non-coding RNAs with regulatory roles but this is not documented for ZNF738 pseudogene specifically[5]. In conclusion, Zinc finger protein 738 pseudogene is not a functional therapeutic target and should not be considered as such in drug discovery or biomarker studies[11][5].
None. Pseudogenes are not targeted pharmacologically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 738 pseudogene (No widely used canonical abbreviation; sometimes referenced as ZNF738P or similar pseudogene notation.).